Apparent volume of distribution, pulmonary clearance and bioavailability of volatile or gaseous compounds after peripheral intravenous dosing.
D000335:Aerosol Propellants; D000818:Animals; D001702:Biopharmaceutics; D001835:Body Weight; D002302:Cardiac Output; D004285:Dogs; D005740:Gases / Q000008:administration & dosage / Q000378:metabolism*; D006845:Hydrocarbons, Fluorinated / Q000378:metabolism; D007275:Injections, Intravenous; D007700:Kinetics; D008168:Lung / Q000378:metabolism*; D008433:Mathematics; D008954:Models, Biological; D011652:Pulmonary Circulation; D013997:Time Factors; D014835:Volatilization
D000335:Aerosol Propellants; D005740:Gases; D006845:Hydrocarbons, Fluorinated